Quantidex qpcr BCR ABL is kit reagents and quantidex qpcr BCR-ABL minor kit reagents.
Active Purchase Order Awarded Last action
- Contract number
- W81K0022P0237
- Awardee
-
Asuragen Incorporated UEI E8M9NXN4X4Y7 Part of Bio-Techne Corporation
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $552,493
Award facts
- Opportunity
-
- Sources Sought Notice - Cost-Per-Test - Reagents for BCR-ABL Tests Pre-Solicitation · W81K0022Q0112 · Posted May 19, 2022
- Contract value 75% obligated
- $737,873.00 Current and potential, with all options
- Completion date 81% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- 2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Funding Only Action | -$100,940 | |
| Funding Only Action | $178,300 | |
| Funding Only Action | -$2,375 | |
| Exercise an Option | $0 | |
| Funding Only Action | $171,490 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $180,888 | |
| Funding Only Action | $72,600 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | -$105,060 | |
| Funding Only Action | $157,590 | |
| Original award | $0 |
Show all 14
About this award
The Defense Health Agency awarded a purchase order to Asuragen Incorporated for Quantidex qPCR BCR-ABL IS Kit Reagents and Quantidex qPCR BCR-ABL Minor Kit Reagents with a ceiling value of $737,873.00, effective October 1, 2022 and with ultimate completion by September 30, 2027. No set-aside was used. Performance is at Fort Sam Houston, Texas. The reagents support BCR-ABL testing on Applied Biosystems 7500 Fast Dx Real-Time PCR instruments at Brooke Army Medical Center and must meet FDA approval requirements, with a minimum six-month shelf life from receipt and five-hour or less turnaround time for test results. The requirement originated from a pre-solicitation posted May 19, 2022, by the Regional Health Contracting Office–Central on behalf of the San Antonio Military Medical Center.
Quick answers
Who was awarded contract W81K0022P0237?
W81K0022P0237 was awarded to Asuragen Incorporated by Medical Command (Department of the Army) on October 1, 2022.
How much is contract W81K0022P0237 worth?
The government has obligated $552,493 on W81K0022P0237. Its current value, with exercised options, is $737,873.
Which agency awarded contract W81K0022P0237?
Medical Command (Department of the Army) awarded W81K0022P0237, with funding from Defense Health Agency (Department of Defense).
Was contract W81K0022P0237 competed?
The extent of competition for W81K0022P0237 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award